keynote-189: chemotherapy and pembrolizumab in mnsclc
Published 6 years ago • 741 plays • Length 5:42Download video MP4
Download video MP3
Similar videos
-
2:02
keynote-189: chemo plus pembrolizumab for nsclc
-
4:53
chemo-immunotherapy in nsclc: the keynote-189 trial
-
4:21
optimizing use of the keynote-189 regimen in mnsclc
-
4:05
pembrolizumab chemotherapy in newly diagnosed nsclc
-
7:01
actual use of pembrolizumab and chemotherapy in nsclc
-
1:55
dr. kim on the keynote-189 trial in metastatic nsclc
-
10:32
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
3:13
latest data from keynote 42: pembrolizumab vs chemotherapy in treatment-naive patients (pts) wit...
-
4:39
chemotherapy pembrolizumab: a new standard of care?
-
10:34
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
2:25
dr. gadgeel on updated keynote-189 data in nsclc
-
10:34
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
2:44
pembrolizumab and chemotherapy in advanced nsclc
-
8:19
keynote trial data: pembrolizumab’s role in nsclc
-
5:00
implications for pembrolizumab in nsclc
-
3:03
keynote-189 update: 4-year follow-up of fl pembro chemo metastatic nsclc
-
1:53
dr. spigel on pembrolizumab/chemo combo in first-line nsclc
-
2:15
dr. ramalingam on pembrolizumab and chemotherapy in nsclc
-
6:32
keynote-189: clinical implications in patients with less than 1% tumor pd-l1 expression (bmic-033)